You’re invited to listen to the first Dealmakers
Forum
90-minute audio conference on what’s next
in the
health care merger and acquisition market.
Hear expert commentary on emerging trends, biggest deals, key players,
and get an advance report on healthcare M&A activity by sector.
Our panel of dealmakers provide market intelligence behind the
strategies they’re advising for the last half of 2005 and beyond.
When you participate in the conference, you also gain the opportunity to
ask the panel direct questions, and answer such questions as:
|
√ |
Which trends are
impacting health care M&A deals for the remainder of this year? |
|
√ |
How are acquirers
valuing targets that have little or
no revenues or profits? |
|
√ |
What’s ahead for big
pharma as blockbuster drugs
go off patent? |
|
√ |
Will acquisition
pricing for medical device deals continue to increase? |
|
√ |
What developments are
impacting key health care service and technology sectors? |
|
√ |
Will the flurry of
overseas generic drug mergers continue, or has volume peaked? |
|
√ |
Which health care
sectors are ramping up activity? Where are the best deals? |
Cost:
$295 for 2 CD-set or transcript (pdf)
Program Materials:
In addition to the audio presentation on CD, or the complete transcript, you will receive a PowerPoint presentation for this event
and a complimentary report of health care M&A activity by sector, "Deals and
Dealmakers 2005". |
Featured Speakers:
Stephen M. Monroe, Managing Editor of The SeniorCare
Investor, The Health Care M&A Monthly, and Healthcare Corporate Finance
News newsletters
James Forbes, Global Head, Healthcare Investment Banking,
Merrill Lynch
David Ertel, Executive Director, Head of Healthcare,
Morgan StanleyDavid S.B. Lang, Managing Director,
TA Associates Alan Hartman, Managing Director, Global
Head, Healthcare M&A Group, Merrill Lynch Robert Collins,
Executive Director, Healthcare M&A, Morgan Stanley |
|